Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Overcoming adaptive therapy resistance in AML by targeting immune response pathways.
Journal: Science translational medicine
Published: February 04, 2019
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.
Journal: The Journal of clinical investigation
Published: February 02, 2019
Deconstructing innate immune signaling in myelodysplastic syndromes.
Journal: Experimental hematology
Published: May 22, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026